Year |
Citation |
Score |
2023 |
Fan Y, Zhang B, Du X, Wang B, Yan Q, Guo L, Yao W. Regulating Tumorigenicity and Cancer Metastasis through TRKA Signaling. Current Cancer Drug Targets. PMID 37670705 DOI: 10.2174/1568009623666230904150957 |
0.377 |
|
2019 |
Li L, Fan Y, Huang X, Luo J, Zhong L, Shu XS, Lu L, Xiang T, Chan ATC, Yeo W, Chen C, Chan WY, Huganir RL, Tao Q. Tumor Suppression of Ras GTPase-Activating Protein RASA5 through Antagonizing Ras Signaling Perturbation in Carcinomas. Iscience. 21: 1-18. PMID 31654850 DOI: 10.1016/J.Isci.2019.10.007 |
0.684 |
|
2018 |
Zhang Y, Fan J, Fan Y, Li L, He X, Xiang Q, Mu J, Zhou D, Sun X, Yang Y, Ren G, Tao Q, Xiang T. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Clinical Epigenetics. 10: 26. PMID 30359298 DOI: 10.1186/S13148-018-0459-2 |
0.659 |
|
2017 |
Fan Y, Yue J, Xiao M, Han-Zhang H, Wang YV, Ma C, Deng Z, Li Y, Yu Y, Wang X, Niu S, Hua Y, Weng Z, Atadja P, Li E, et al. FXR1 regulates transcription and is required for tumor growth in TP53 homozygous deletion human cancers. Elife. 6. PMID 28767039 DOI: 10.7554/Elife.26129 |
0.416 |
|
2016 |
Xiang T, Fan Y, Li C, Li L, Ying Y, Mu J, Peng W, Feng Y, Oberst M, Kelly K, Ren G, Tao Q. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells. Oncotarget. PMID 27708215 DOI: 10.18632/Oncotarget.12341 |
0.644 |
|
2015 |
Zhang L, Zhang Q, Li L, Wang Z, Ying J, Fan Y, He Q, Lv T, Han W, Li J, Yang Y, Xu B, Wang L, Liu Q, Sun Y, et al. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer. Journal of Molecular Medicine (Berlin, Germany). 93: 691-701. PMID 25648635 DOI: 10.1007/S00109-015-1255-5 |
0.669 |
|
2015 |
Li L, Zhang Y, Fan Y, Sun K, Su X, Du Z, Tsao SW, Loh TK, Sun H, Chan AT, Zeng YX, Chan WY, Chan FK, Tao Q. Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes. Epigenomics. 7: 155-73. PMID 25479246 DOI: 10.2217/Epi.14.79 |
0.652 |
|
2015 |
Han Y, Zheng YL, Fan YP, Liu MH, Lu XY, Tao Q. Association of adiponectin gene polymorphism 45TG with gestational diabetes mellitus diagnosed on the new IADPSG criteria, plasma adiponectin levels and adverse pregnancy outcomes. Clinical and Experimental Medicine. 15: 47-53. PMID 24664457 DOI: 10.1007/s10238-014-0275-8 |
0.355 |
|
2014 |
Zhang Q, Zhang L, Li L, Wang Z, Ying J, Fan Y, Xu B, Wang L, Liu Q, Chen G, Tao Q, Jin J. Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis. Cancer Letters. 354: 227-34. PMID 25109451 DOI: 10.1016/J.Canlet.2014.07.040 |
0.758 |
|
2014 |
Li H, Li J, Su Y, Fan Y, Guo X, Li L, Su X, Rong R, Ying J, Mo X, Liu K, Zhang Z, Yang F, Jiang G, Wang J, et al. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth. Oncogene. 33: 3109-18. PMID 23893243 DOI: 10.1038/Onc.2013.282 |
0.759 |
|
2013 |
Shu XS, Li L, Ji M, Cheng Y, Ying J, Fan Y, Zhong L, Liu X, Tsao SW, Chan AT, Tao Q. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis. 34: 1984-93. PMID 23677067 DOI: 10.1093/Carcin/Bgt165 |
0.774 |
|
2012 |
Vrzalikova K, Leonard S, Fan Y, Bell A, Vockerodt M, Flodr P, Wright KL, Rowe M, Tao Q, Murray PG. Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas. Pathogens (Basel, Switzerland). 1: 83-101. PMID 25436766 DOI: 10.3390/Pathogens1020083 |
0.55 |
|
2012 |
Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y, Tan J, Cao Y, Tsao SW, Srivastava G, Chan ATC, Tao Q. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/Β-catenin signaling and silenced in common carcinomas Oncogene. 31: 3901-3912. PMID 22139084 DOI: 10.1038/Onc.2011.541 |
0.766 |
|
2011 |
Fan Y, Ying Y, Li L, Chan AT, Tao Q. Abstract 2191: The Wnt/DVL signaling antagonist DACT2 is a pro-apoptotic tumor suppressor epigenetically silenced in multiple tumors and inhibits tumor cell proliferation and migration Cancer Research. 71: 2191-2191. DOI: 10.1158/1538-7445.Am2011-2191 |
0.721 |
|
2010 |
Murray PG, Fan Y, Davies G, Ying J, Geng H, Ng KM, Li H, Gao Z, Wei W, Bose S, Anderton J, Kapatai G, Reynolds G, Ito A, Marafioti T, et al. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. The American Journal of Pathology. 177: 1480-90. PMID 20709797 DOI: 10.2353/Ajpath.2010.100052 |
0.708 |
|
2010 |
Xiang T, Li L, Fan Y, Jiang Y, Ying Y, Putti TC, Tao Q, Ren G. PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer. Cancer Biology & Therapy. 10: 520-7. PMID 20657189 DOI: 10.4161/Cbt.10.5.12726 |
0.671 |
|
2010 |
Zhang Q, Ying J, Li J, Fan Y, Poon FF, Ng KM, Tao Q, Jin J. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage. The Journal of Urology. 184: 731-7. PMID 20639048 DOI: 10.1016/J.Juro.2010.03.108 |
0.743 |
|
2010 |
Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biology & Therapy. 10: 617-24. PMID 20603606 DOI: 10.4161/Cbt.10.6.12609 |
0.746 |
|
2009 |
Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene. 28: 2466-75. PMID 19448674 DOI: 10.1038/Onc.2009.92 |
0.725 |
|
Show low-probability matches. |